title: [Changes in cardiovascular risk factors among men in Oslo during 28 years].
abstract: BACKGROUND
  The aim of the study was to measure changes in known risk factors for cardiovascular disease among men over a period of 28 years.
  
  
  METHODS
  The present cohort study comprises a selection of men previously included in the Oslo-study of 1972/73. The men selected, were either followed-up in the Oslo II study (n = 5,323), or were included in five other studies in the period 1996-2001 (n = 1,834). The total material is named The second screening of the Oslo-study and consists of 7157 men.
  
  
  RESULTS
  The men were born between 1923 and 1952. All age groups showed a marked increase in mean weight by 4.4 Kg. Body Mass Index changed from 24.3 to 26.4 kg/m2 , coinciding with reduced level of physical activity in all age groups. A comparison of body mass index in men of the same age in 1972/73 and 2000, show a mean increase in body mass index of two units. An increase of 0.30 mmol/L glucose (non-fasting) was observed. Total cholesterol decreased from 6.19 to 5.95 mmol/L and triglycerides remained unchanged (1.89 to 1.87 mmol/L). Systolic blood pressure increased but not the diastolic pressure. Overall 30.8 % of the men took medication for increased blood pressure, versus 3.1 % at the first screening. The percentage of daily smokers decreased from 44.2 % to 17.4 %.
  
  
  CONCLUSIONS
  The most encouraging result was the strong reduction in number of daily smokers. The study confirms the weight increase observed among men in Norway.
authors.affiliation: Nasjonalt kunnskapssenter for helsetjenesten, Postboks 7004 St. Olavs plass, 0130 Oslo. lise.lund.haheim@kunnskapssenteret.no
authors.forename: Lise Lund
authors.initials: LL
authors.lastname: Håheim
authors.forename: Ingar
authors.initials: I
authors.lastname: Holme
authors.forename: Anne Johanne
authors.initials: AJ
authors.lastname: Søgaard
authors.forename: Per G
authors.initials: PG
authors.lastname: Lund-Larsen
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000209:etiology*; D015331:Cohort Studies; D005500:Follow-Up Studies; D006306:Health Surveys; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D009664:Norway / Q000453:epidemiology; D011446:Prospective Studies; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects
chemical_list: D000959:Antihypertensive Agents; D015415:Biomarkers; D001786:Blood Glucose; D008055:Lipids